期刊文献+

维吾尔族前列腺癌与雄激素受体CAG重复多态性的关系 被引量:3

原文传递
导出
摘要 目的 探讨雄激素受体 (androgenreceptor ,AR )基因CAG重复长度与维吾尔族前列腺癌(prostatecancer ,PC)危险性及临床表现的关系。方法 应用PCR和直接测序的方法对维吾尔族 3 1例PC和 80名健康老年男性患者外周血标本进行AR基因CAG重复长度测定。结果 PC和对照组AR基因CAG重复长度平均为 2 2 .3和 2 2 .8,范围为 13 3 0 ,两者比较差异无显著性 (P =0 .5 72 )。AR基因CAG重复长度 <2 2与≥ 2 2比较 ,OR值为 2 .3 2 ( 95 %可信区间为 1.0 0 5 .46,P =0 .0 5 ) ,AR基因CAG重复长度与PC发病年龄 (相关系数 0 .2 0 1,P =0 .2 8)、前列腺特异抗原 (相关系数 -0 .0 92 ,P =0 .62 )无相关性 ,与前列腺癌分级也无关 (P >0 .0 5 )。结论 短的AR基因CAG重复长度与维吾尔族前列腺癌的危险性有关 ,而与前列腺癌的发病年龄、PSA水平及病理分级无关。
出处 《中华医学遗传学杂志》 CAS CSCD 2004年第4期415-416,共2页 Chinese Journal of Medical Genetics
基金 新疆维吾尔自治区少数民族科技骨干人才科研专项基金资助 (2 0 0 1 30 )~~
  • 相关文献

参考文献6

  • 1Irvine RA, Yu MC, Ross RK, et al. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res, 1995, 55:1937-1940.
  • 2Andrew SE, Goldberg YP, Hayden MR, et al. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet, 1997, 6:2005-2010.
  • 3Balic I, Graham ST, Troyer DA, et al. Androgen receptor length polymophism associated with prostate cancer risk in Hispanic men. J Urol, 2002,168:2245-2248.
  • 4Hsing AW, Gao YT, Wu G, et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res, 2000, 60:5111-5116.
  • 5Mononen N, Ikonen T, Autio V, et al. Androgen receptor CAG polymorphism and prostate cancer risk. Hum Genet, 2002, 111:166-171.
  • 6Beilin J, Harewood L, Frydenberg M, et al. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects. Cancer, 2001, 92:941-949.

同被引文献65

  • 1徐郑,钱立新.雄激素受体及前列腺特异性抗原基因多态性与前列腺癌易感性[J].国际泌尿系统杂志,2006,26(2):213-215. 被引量:2
  • 2何青芳,俞敏,王立新.血管紧张素Ⅱ-1型受体基因多态性与原发性高血压的相关性研究[J].中华检验医学杂志,2006,29(9):818-819. 被引量:3
  • 3余凯远,翁志梁,王思齐,余志贤,陈伟,吴秀玲,李澄棣.间歇性与持续性雄激素阻断治疗晚期前列腺癌疗效比较[J].中华泌尿外科杂志,2006,27(11):761-764. 被引量:31
  • 4Endre T,Mattiasson I,Berglund G,et al.Low testosterone and insulin resistance in hypertension-prone men[J].J Hum Hypertens,1996,10(11):755 -761.
  • 5Baudin B.Polymorphism in angiotensin Ⅱ receptor genes and hypertension[J].Exp Physio1,2005,90:277-282.
  • 6Zhou JB,Yang JK.Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension[J].Journal of Renin-Angiotensin-Aldosterone System,2009,10:31-34.
  • 7Yeh S,Sampson ER,Lee DK,et al.Functional analysis of androgen receptor N terminal and ligand binding domain interacting coregulators in prostate cancer[J].J Formos Med Assoc,2000,99 (12):885-894.
  • 8Guo Z,Benten WP,Krucken J,et al.Nongenomic testosterone calcium signaling Genotropie actions in androgen receptor free macrophages[J].J Biol Chem,2002,277:29600-29607.
  • 9Whitworth JA.World Health Organization,International Society of Hypertension Writing Group.2003 World Health Organization (WHO) Plnternational Society of Hypertension (ISH) statement on management of hypertension[J].J Hypertens,2003,21:1983-1992.
  • 10Ellis JA,Stebbing M,Harrap SB.Polymorphism of the androgen receptor gene is associated with male pattern baldness[J].J Invest Dermato1,2001,116:452-455.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部